In 2003 was created GlenRock Israel, which is appeared as VC.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the GlenRock Israel, startups are often financed by Lightspeed Venture Partners, Viola Ventures, Steamboat Ventures. The meaningful sponsors for the fund in investment in the same round are Lightspeed Venture Partners, Gemini Israel Ventures, Viola Ventures. In the next rounds fund is usually obtained by Lightspeed Venture Partners, Viola Ventures, Gemini Israel Ventures.
Among the most successful fund investment fields, there are Network Security, Enterprise Software. Among the various public portfolio startups of the fund, we may underline Mobileye, LifeBond Ltd., Ecoppia The fund has exact preference in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Besides them, we counted 4 critical employees of this fund in our database.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2014. Considering the real fund results, this VC is 15 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this GlenRock Israel performs on 19 percentage points less the average number of lead investments. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year. When the investment is from GlenRock Israel the average startup value is 100-500 millions dollars.
Related Funds
Funds with similar focus
Fund Name | Location |
ActnerLab | Seoul, Seoul-t'ukpyolsi, South Korea |
ADvantage Sports Tech Fund | Israel, Jerusalem, Jerusalem District |
Binhai Capital | China, Guangdong, Tianjin |
Calistar | China, Jiangxi, Tianbao |
Central Virginia Angels | - |
China Resources Technology | - |
DCapital | - |
Event | - |
Fortune Capital | Coral Gables, Florida, United States |
GMO Internet | Japan, Tokyo |
Greenfield Advisory | - |
Hemingwei Partners | - |
M Krishna Sindhuri Private Trust | - |
Nippon Technology Venture Partners | Japan, Setagaya |
Oregon Technology Business Center | Beaverton, Oregon, United States |
Pusu Capital | China, Guangdong, Shenzhen |
Shanghai Ruihexin Investment Management | China, Minhang, Shanghai |
Synovia Capital | - |
The Home Depot | Atlanta, Georgia, United States |
Woofoo Capital | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Treetoscope | $7M | 20 Sep 2023 | Tel Aviv, Tel Aviv, Israel | ||
Quris Technologies | $9M | 20 Dec 2022 | Tel Aviv, Tel Aviv, Israel | ||
Constru | $8M | 28 Sep 2022 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
AcadeMe+ | $750K | 01 Apr 2022 | Tel Aviv, Tel Aviv, Israel | ||
Quris Technologies | $19M | 11 Jan 2022 | Tel Aviv, Tel Aviv, Israel | ||
Cylus | $30M | 15 Dec 2021 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Karamba Security | $10M | 02 Dec 2021 | Michigan, United States | ||
Lydus Medical | $2M | 24 May 2021 | Israel, North District, Israel | ||
Nurami Medical | $6M | 02 Nov 2020 | Israel, Nazareth |
– Lydus Medical, a Ra’Anana, Israel-based developer of a novel product line for automating the creation of small blood vessel anastomoses, raised $2.7m in Pre-A funding.
The round was led by an undisclosed US based strategic player with the participation from Sanara Ventures, and existing backers Mor Research, Technion and Leon Recanati’s private equity investment company, Glenrock.
The company intends to use the funds to accelerate FDA clearance while scaling product development and prepare for market entry.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Treetoscope | $7M | 20 Sep 2023 | Tel Aviv, Tel Aviv, Israel | ||
Quris Technologies | $9M | 20 Dec 2022 | Tel Aviv, Tel Aviv, Israel | ||
Constru | $8M | 28 Sep 2022 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
AcadeMe+ | $750K | 01 Apr 2022 | Tel Aviv, Tel Aviv, Israel | ||
Quris Technologies | $19M | 11 Jan 2022 | Tel Aviv, Tel Aviv, Israel | ||
Cylus | $30M | 15 Dec 2021 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Karamba Security | $10M | 02 Dec 2021 | Michigan, United States | ||
Lydus Medical | $2M | 24 May 2021 | Israel, North District, Israel | ||
Nurami Medical | $6M | 02 Nov 2020 | Israel, Nazareth |